Effectiveness of Saroglitazar in <scp>MASLD</scp> Patients: A Prospective, Real‐World Assessment of Liver and Metabolic Health
Despite a slight increase in BMI, Saroglitazar significantly improved transient elastography parameters and hepatic parameters in MASLD patients, suggesting that this drug alone effectively manages MASLD-related metabolic and hepatic dysfunctions.
Authors
- Rajiv Awasthi
- Harshita Lachhwani
- MUKULESH GUPTA
- Dinesh Kumar
- Kumar Praful Chandra
Institutions
- University of Lucknow (IN)
- Diabetes Australia (AU)
- India Diabetes Research Foundation (IN)
- Diabetes Care & Hormone Clinic (IN)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1002/edm2.70144
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00